U.K. switch proposal
This article was originally published in The Tan Sheet
Executive Summary
The Medicines and Healthcare products Regulatory Agency announces Feb. 7 it is seeking comments on the reclassification of Cyklo-f 500 mg tablets from prescription only status (POM) to pharmacy availability (P). The active ingredient, tranexamic acid, is indicated for menorrhagia, or heavy menstrual bleeding experienced by women over several cycles. The condition can interfere with the physical, emotional, social and material quality-of-life for women who suffer from it, MHRA states in materials on the drug. Tranexamic acid has been available without a prescription for menorrhagia in Sweden since 1997. Comments are due March 20...